Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page
- Check5 days agoChange DetectedMinor site update: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed from the page, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding status banner was removed from the page; it previously warned about potential delays in updates.SummaryDifference0.3%

- Check55 days agoChange DetectedThe DENIVOS study page shows only minor administrative edits, including formatting tweaks and an updated timestamp. There are no changes to core trial details, eligibility criteria, or the list of participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange Detected- Added a government funding notice and open status details (affects trust and usage guidance). - Updated version from v3.1.0 to v3.2.0 and removed the old version reference.SummaryDifference3%

- Check91 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.